Racheli Ofir

Chief Executive Officer at

Betalin Therapeutics Ltd.

Consumer Services

Health Technology

Technology Services

Profile

Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd. Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.

Racheli Ofir active positions

Companies	Position	Start
Betalin Therapeutics Ltd. Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology	Chief Executive Officer	01/12/2022

All active positions of Racheli Ofir

Former positions of Racheli Ofir

Companies	Position	End
PLURI INC.	Chief Tech/Sci/R&D Officer	01/05/2022

See the detail of Racheli Ofir's experience

Training of Racheli Ofir

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Racheli Ofir's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Pluri, Inc. Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation	Health Technology
Technion-Israel Institute of Technology Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Israel Institute of Technology Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Betalin Therapeutics Ltd. Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology	Technology Services